 |
PDBsum entry 2qfb
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Crystal structure of the regulatory domain of human rig-i with bound zn
|
|
Structure:
|
 |
Probable atp-dependent RNA helicase ddx58. Chain: a, b, c, d, e, f, g, h, i, j. Fragment: regulatory domain. Synonym: dead-box protein 58, retinoic acid-inducible gene 1 protein, rig-1, rig-i. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: ddx58. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
3.00Å
|
R-factor:
|
0.248
|
R-free:
|
0.285
|
|
|
Authors:
|
 |
S.Cui,A.Lammens,K.Lammens,K.P.Hopfner
|
Key ref:
|
 |
S.Cui
et al.
(2008).
The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I.
Mol Cell,
29,
169-179.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
27-Jun-07
|
Release date:
|
12-Feb-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
O95786
(DDX58_HUMAN) -
Antiviral innate immune response receptor RIG-I from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
925 a.a.
121 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.6.4.13
- Rna helicase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + H2O = ADP + phosphate + H+
|
 |
 |
 |
 |
 |
ATP
|
+
|
H2O
|
=
|
ADP
|
+
|
phosphate
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Mol Cell
29:169-179
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I.
|
|
S.Cui,
K.Eisenächer,
A.Kirchhofer,
K.Brzózka,
A.Lammens,
K.Lammens,
T.Fujita,
K.K.Conzelmann,
A.Krug,
K.P.Hopfner.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The ATPase RIG-I senses viral RNAs that contain 5'-triphosphates in the
cytoplasm. It initiates a signaling cascade that activates innate immune
response by interferon and cytokine production, providing essential antiviral
protection for the host. The mode of RNA 5'-triphosphate sensing by RIG-I
remains elusive. We show that the C-terminal regulatory domain RD of RIG-I binds
viral RNA in a 5'-triphosphate-dependent manner and activates the RIG-I ATPase
by RNA-dependent dimerization. The crystal structure of RD reveals a
zinc-binding domain that is structurally related to GDP/GTP exchange factors of
Rab-like GTPases. The zinc coordination site is essential for RIG-I signaling
and is also conserved in MDA5 and LGP2, suggesting related RD domains in all
three enzymes. Structure-guided mutagenesis identifies a positively charged
groove as likely 5'-triphosphate-binding site of RIG-I. This groove is distinct
in MDA5 and LGP2, raising the possibility that RD confers ligand specificity.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Biochemical Analysis of RIG-I Variants (A)
RIG-I and MDA5 variants used in this study. (B) Catalytic
efficiency (k[cat] K[m]^−1) of WT RIG-I and ΔCARD-RIG-I,
RIG-I-ΔRD and the DECH domain for pppRVL (black bars), and
nonphosphorylated dsRNA (white bars). Error bars represent
standard errors of the nonlinear regression analysis
(Supplemental Data).
|
 |
Figure 6.
Figure 6. Localization of the RNA 5′-Triphosphate-Binding
Site on RD (A) Electrostatic surface potential (ranging
from blue = 9 kT/e to red = −9 kT/e), displayed in two
different views (left, “standard view” used in all other
figures; right, 180° rotation around vertical axis). The
sites of mutated residues are annotated. A prominent positive
groove indicates a likely phosphate-binding site for RNA
5′-triphosphates. (B) Surface conservation of RIG-I RD in
standard view, ranging from dark red (invariant) to white
(unconserved). A patch of high sequence conservation colocalizes
with the positively charged groove (A, left). (C)
Localization of the mutations, shown in a ribbon model with
added side chains. The effect of alanine mutations on pppRVL
binding in vitro is highlighted by different colors: red, large
effect; orange, medium effect. (D) Fluorescence anisotropy
changes (ΔA) of fluorescently labeled pppRVL in response to
titration with WT RD (filled circle, K[d] = 217 ± 11 nM)
and mutated RD using the setup of Figure 2A. Two control
mutations of conserved residues of the convex side of RD,
K807→A (half-filled right-facing triangle, K[d] = 254 ±
16 nM) and D836→A (half-filled square, K[d] = 185 ± 15
nM), did not significantly alter binding affinity of pppRVL.
Several mutations in the positively charged groove reduced
binding affinity. H830→A (open left-facing triangle, K[d] =
500 ± 30 nM), I875→A (open diamond, K[d] = 1.0 ±
0.1 μM), and K888→A (open down-facing triangle, K[d] = 1.0
± 0.2 μM) significantly reduced binding affinity.
K858→A (open square, K[d] > 5 μM), however, dramatically
reduced binding affinity, indicating that this residue is a
central recognition site for pppRVL. (E) HEK293 cells were
transfected with IFN-β promoter luciferase reporter constructs
and renilla luciferase control vector as well as plasmids
expressing WT RIG-I or indicated mutants (10 and 100 ng per
transfection). The left panel depicts the more conservative
alanine mutants, while the right panel depicts the stronger
glutamate charge reversal mutants. Cells were stimulated with
transfected pppVSVL or infected with VSV-M51R. IFN-β promoter
activity was measured by dual luciferase assay after 18 hr (fold
induction compared to mock-treated empty vector control). Mean
values and standard deviations (error bars) of three independent
experiments are shown. (F) Proposed model for RNA
5′-triphosphate (gray with red phosphates) activation of RIG-I
by ligand-induced dimer formation of RD (yellow with magenta
zinc ion). RNA stoichiometry and domain-domain interactions are
tentative.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Mol Cell
(2008,
29,
169-179)
copyright 2008.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.García-Sastre
(2011).
2 methylate or not 2 methylate: viral evasion of the type I interferon response.
|
| |
Nat Immunol,
12,
114-115.
|
 |
|
|
|
|
 |
A.Schmidt,
S.Endres,
and
S.Rothenfusser
(2011).
Pattern recognition of viral nucleic acids by RIG-I-like helicases.
|
| |
J Mol Med,
89,
5.
|
 |
|
|
|
|
 |
C.Lu,
C.T.Ranjith-Kumar,
L.Hao,
C.C.Kao,
and
P.Li
(2011).
Crystal structure of RIG-I C-terminal domain bound to blunt-ended double-strand RNA without 5' triphosphate.
|
| |
Nucleic Acids Res,
39,
1565-1575.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.Jankowsky
(2011).
RNA helicases at work: binding and rearranging.
|
| |
Trends Biochem Sci,
36,
19-29.
|
 |
|
|
|
|
 |
E.Miranda,
F.Forafonov,
and
A.Tavassoli
(2011).
Deciphering interactions used by the influenza virus NS1 protein to silence the host antiviral sensor protein RIG-I using a bacterial reverse two-hybrid system.
|
| |
Mol Biosyst,
7,
1042-1045.
|
 |
|
|
|
|
 |
H.Feng,
H.Liu,
R.Kong,
L.Wang,
Y.Wang,
W.Hu,
and
Q.Guo
(2011).
Expression profiles of carp IRF-3/-7 correlate with the up-regulation of RIG-I/MAVS/TRAF3/TBK1, four pivotal molecules in RIG-I signaling pathway.
|
| |
Fish Shellfish Immunol,
30,
1159-1169.
|
 |
|
|
|
|
 |
J.Ye,
S.Chen,
and
T.Maniatis
(2011).
Cardiac glycosides are potent inhibitors of interferon-β gene expression.
|
| |
Nat Chem Biol,
7,
25-33.
|
 |
|
|
|
|
 |
K.H.Kok,
P.Y.Lui,
M.H.Ng,
K.L.Siu,
S.W.Au,
and
D.Y.Jin
(2011).
The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response.
|
| |
Cell Host Microbe,
9,
299-309.
|
 |
|
|
|
|
 |
K.Onoguchi,
M.Yoneyama,
and
T.Fujita
(2011).
Retinoic acid-inducible gene-I-like receptors.
|
| |
J Interferon Cytokine Res,
31,
27-31.
|
 |
|
|
|
|
 |
K.Pachler,
and
R.Vlasak
(2011).
Influenza C virus NS1 protein counteracts RIG-I-mediated IFN signalling.
|
| |
Virol J,
8,
48.
|
 |
|
|
|
|
 |
R.Barbalat,
S.E.Ewald,
M.L.Mouchess,
and
G.M.Barton
(2011).
Nucleic acid recognition by the innate immune system.
|
| |
Annu Rev Immunol,
29,
185-214.
|
 |
|
|
|
|
 |
S.A.McCartney,
W.Vermi,
S.Lonardi,
C.Rossini,
K.Otero,
B.Calderon,
S.Gilfillan,
M.S.Diamond,
E.R.Unanue,
and
M.Colonna
(2011).
RNA sensor-induced type I IFN prevents diabetes caused by a β cell-tropic virus in mice.
|
| |
J Clin Invest,
121,
1497-1507.
|
 |
|
|
|
|
 |
S.Hayakawa,
S.Shiratori,
H.Yamato,
T.Kameyama,
C.Kitatsuji,
F.Kashigi,
S.Goto,
S.Kameoka,
D.Fujikura,
T.Yamada,
T.Mizutani,
M.Kazumata,
M.Sato,
J.Tanaka,
M.Asaka,
Y.Ohba,
T.Miyazaki,
M.Imamura,
and
A.Takaoka
(2011).
ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses.
|
| |
Nat Immunol,
12,
37-44.
|
 |
|
|
|
|
 |
T.Matsumiya,
T.Imaizumi,
H.Yoshida,
and
K.Satoh
(2011).
Antiviral signaling through retinoic acid-inducible gene-I-like receptors.
|
| |
Arch Immunol Ther Exp (Warsz),
59,
41-48.
|
 |
|
|
|
|
 |
A.Baum,
and
A.García-Sastre
(2010).
Induction of type I interferon by RNA viruses: cellular receptors and their substrates.
|
| |
Amino Acids,
38,
1283-1299.
|
 |
|
|
|
|
 |
A.Baum,
R.Sachidanandam,
and
A.García-Sastre
(2010).
Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing.
|
| |
Proc Natl Acad Sci U S A,
107,
16303-16308.
|
 |
|
|
|
|
 |
A.V.Kubarenko,
S.Ranjan,
E.Colak,
J.George,
M.Frank,
and
A.N.Weber
(2010).
Comprehensive modeling and functional analysis of Toll-like receptor ligand-recognition domains.
|
| |
Protein Sci,
19,
558-569.
|
 |
|
|
|
|
 |
B.Jin,
T.Sun,
X.H.Yu,
C.Q.Liu,
Y.X.Yang,
P.Lu,
S.F.Fu,
H.B.Qiu,
and
A.E.Yeo
(2010).
Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant.
|
| |
J Biomed Biotechnol,
2010,
690438.
|
 |
|
|
|
|
 |
C.Lu,
H.Xu,
C.T.Ranjith-Kumar,
M.T.Brooks,
T.Y.Hou,
F.Hu,
A.B.Herr,
R.K.Strong,
C.C.Kao,
and
P.Li
(2010).
The structural basis of 5' triphosphate double-stranded RNA recognition by RIG-I C-terminal domain.
|
| |
Structure,
18,
1032-1043.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Matranga,
and
A.M.Pyle
(2010).
Double-stranded RNA-dependent ATPase DRH-3: insight into its role in RNAsilencing in Caenorhabditis elegans.
|
| |
J Biol Chem,
285,
25363-25371.
|
 |
|
|
|
|
 |
C.T.Ranjith-Kumar,
Y.Lai,
R.T.Sarisky,
and
C.Cheng Kao
(2010).
Green tea catechin, epigallocatechin gallate, suppresses signaling by the dsRNA innate immune receptor RIG-I.
|
| |
PLoS One,
5,
e12878.
|
 |
|
|
|
|
 |
C.Zheng,
and
H.Wu
(2010).
RIG-I "sees" the 5'-triphosphate.
|
| |
Structure,
18,
894-896.
|
 |
|
|
|
|
 |
E.Nistal-Villán,
M.U.Gack,
G.Martínez-Delgado,
N.P.Maharaj,
K.S.Inn,
H.Yang,
R.Wang,
A.K.Aggarwal,
J.U.Jung,
and
A.García-Sastre
(2010).
Negative role of RIG-I serine 8 phosphorylation in the regulation of interferon-beta production.
|
| |
J Biol Chem,
285,
20252-20261.
|
 |
|
|
|
|
 |
H.M.Liu,
and
M.Gale
(2010).
Hepatitis C Virus Evasion from RIG-I-Dependent Hepatic Innate Immunity.
|
| |
Gastroenterol Res Pract,
2010,
548390.
|
 |
|
|
|
|
 |
J.H.Ryu,
C.H.Kim,
and
J.H.Yoon
(2010).
Innate immune responses of the airway epithelium.
|
| |
Mol Cells,
30,
173-183.
|
 |
|
|
|
|
 |
J.Li,
Y.Liu,
and
X.Zhang
(2010).
Murine coronavirus induces type I interferon in oligodendrocytes through recognition by RIG-I and MDA5.
|
| |
J Virol,
84,
6472-6482.
|
 |
|
|
|
|
 |
J.Rehwinkel,
C.P.Tan,
D.Goubau,
O.Schulz,
A.Pichlmair,
K.Bier,
N.Robb,
F.Vreede,
W.Barclay,
E.Fodor,
and
C.Reis e Sousa
(2010).
RIG-I detects viral genomic RNA during negative-strand RNA virus infection.
|
| |
Cell,
140,
397-408.
|
 |
|
|
|
|
 |
J.Rehwinkel,
and
C.Reis e Sousa
(2010).
RIGorous detection: exposing virus through RNA sensing.
|
| |
Science,
327,
284-286.
|
 |
|
|
|
|
 |
K.Onomoto,
K.Onoguchi,
K.Takahasi,
and
T.Fujita
(2010).
Type I interferon production induced by RIG-I-like receptors.
|
| |
J Interferon Cytokine Res,
30,
875-881.
|
 |
|
|
|
|
 |
L.Fan,
T.Briese,
and
W.I.Lipkin
(2010).
Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction.
|
| |
J Virol,
84,
1785-1791.
|
 |
|
|
|
|
 |
M.Olejniczak,
P.Galka,
and
W.J.Krzyzosiak
(2010).
Sequence-non-specific effects of RNA interference triggers and microRNA regulators.
|
| |
Nucleic Acids Res,
38,
1.
|
 |
|
|
|
|
 |
M.Schlee,
and
G.Hartmann
(2010).
The chase for the RIG-I ligand--recent advances.
|
| |
Mol Ther,
18,
1254-1262.
|
 |
|
|
|
|
 |
M.U.Gack,
E.Nistal-Villán,
K.S.Inn,
A.García-Sastre,
and
J.U.Jung
(2010).
Phosphorylation-mediated negative regulation of RIG-I antiviral activity.
|
| |
J Virol,
84,
3220-3229.
|
 |
|
|
|
|
 |
M.Yoneyama,
and
T.Fujita
(2010).
Recognition of viral nucleic acids in innate immunity.
|
| |
Rev Med Virol,
20,
4.
|
 |
|
|
|
|
 |
S.Myong,
and
T.Ha
(2010).
Stepwise translocation of nucleic acid motors.
|
| |
Curr Opin Struct Biol,
20,
121-127.
|
 |
|
|
|
|
 |
T.Satoh,
H.Kato,
Y.Kumagai,
M.Yoneyama,
S.Sato,
K.Matsushita,
T.Tsujimura,
T.Fujita,
S.Akira,
and
O.Takeuchi
(2010).
LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses.
|
| |
Proc Natl Acad Sci U S A,
107,
1512-1517.
|
 |
|
|
|
|
 |
T.Yamaguchi,
K.Kawabata,
E.Kouyama,
K.J.Ishii,
K.Katayama,
T.Suzuki,
S.Kurachi,
F.Sakurai,
S.Akira,
and
H.Mizuguchi
(2010).
Induction of type I interferon by adenovirus-encoded small RNAs.
|
| |
Proc Natl Acad Sci U S A,
107,
17286-17291.
|
 |
|
|
|
|
 |
V.R.DeFilippis,
D.Alvarado,
T.Sali,
S.Rothenburg,
and
K.Früh
(2010).
Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1.
|
| |
J Virol,
84,
585-598.
|
 |
|
|
|
|
 |
V.R.DeFilippis,
T.Sali,
D.Alvarado,
L.White,
W.Bresnahan,
and
K.J.Früh
(2010).
Activation of the interferon response by human cytomegalovirus occurs via cytoplasmic double-stranded DNA but not glycoprotein B.
|
| |
J Virol,
84,
8913-8925.
|
 |
|
|
|
|
 |
W.Zeng,
L.Sun,
X.Jiang,
X.Chen,
F.Hou,
A.Adhikari,
M.Xu,
and
Z.J.Chen
(2010).
Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity.
|
| |
Cell,
141,
315-330.
|
 |
|
|
|
|
 |
Y.Wang,
J.Ludwig,
C.Schuberth,
M.Goldeck,
M.Schlee,
H.Li,
S.Juranek,
G.Sheng,
R.Micura,
T.Tuschl,
G.Hartmann,
and
D.J.Patel
(2010).
Structural and functional insights into 5'-ppp RNA pattern recognition by the innate immune receptor RIG-I.
|
| |
Nat Struct Mol Biol,
17,
781-787.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.E.Simon,
and
L.Gehrke
(2009).
RNA conformational changes in the life cycles of RNA viruses, viroids, and virus-associated RNAs.
|
| |
Biochim Biophys Acta,
1789,
571-583.
|
 |
|
|
|
|
 |
A.Marschalek,
S.Finke,
M.Schwemmle,
D.Mayer,
B.Heimrich,
L.Stitz,
and
K.K.Conzelmann
(2009).
Attenuation of rabies virus replication and virulence by picornavirus internal ribosome entry site elements.
|
| |
J Virol,
83,
1911-1919.
|
 |
|
|
|
|
 |
A.Schmidt,
T.Schwerd,
W.Hamm,
J.C.Hellmuth,
S.Cui,
M.Wenzel,
F.S.Hoffmann,
M.C.Michallet,
R.Besch,
K.P.Hopfner,
S.Endres,
and
S.Rothenfusser
(2009).
5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I.
|
| |
Proc Natl Acad Sci U S A,
106,
12067-12072.
|
 |
|
|
|
|
 |
C.Kemp,
and
J.L.Imler
(2009).
Antiviral immunity in drosophila.
|
| |
Curr Opin Immunol,
21,
3-9.
|
 |
|
|
|
|
 |
C.S.McAllister,
and
C.E.Samuel
(2009).
The RNA-activated Protein Kinase Enhances the Induction of Interferon-{beta} and Apoptosis Mediated by Cytoplasmic RNA Sensors.
|
| |
J Biol Chem,
284,
1644-1651.
|
 |
|
|
|
|
 |
C.T.Ranjith-Kumar,
A.Murali,
W.Dong,
D.Srisathiyanarayanan,
R.Vaughan,
J.Ortiz-Alacantara,
K.Bhardwaj,
X.Li,
P.Li,
and
C.C.Kao
(2009).
Agonist and Antagonist Recognition by RIG-I, a Cytoplasmic Innate Immunity Receptor.
|
| |
J Biol Chem,
284,
1155-1165.
|
 |
|
|
|
|
 |
D.A.Pippig,
J.C.Hellmuth,
S.Cui,
A.Kirchhofer,
K.Lammens,
A.Lammens,
A.Schmidt,
S.Rothenfusser,
and
K.P.Hopfner
(2009).
The regulatory domain of the RIG-I family ATPase LGP2 senses double-stranded RNA.
|
| |
Nucleic Acids Res,
37,
2014-2025.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Bamming,
and
C.M.Horvath
(2009).
Regulation of signal transduction by enzymatically inactive antiviral RNA helicase proteins MDA5, RIG-I, and LGP2.
|
| |
J Biol Chem,
284,
9700-9712.
|
 |
|
|
|
|
 |
D.Uzri,
and
L.Gehrke
(2009).
Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities.
|
| |
J Virol,
83,
4174-4184.
|
 |
|
|
|
|
 |
D.W.Leung,
N.D.Ginder,
D.B.Fulton,
J.Nix,
C.F.Basler,
R.B.Honzatko,
and
G.K.Amarasinghe
(2009).
Structure of the Ebola VP35 interferon inhibitory domain.
|
| |
Proc Natl Acad Sci U S A,
106,
411-416.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.Hartmann
(2009).
Gene silencing below the immune radar.
|
| |
J Clin Invest,
119,
438-442.
|
 |
|
|
|
|
 |
H.Huthoff,
F.Autore,
S.Gallois-Montbrun,
F.Fraternali,
and
M.H.Malim
(2009).
RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1.
|
| |
PLoS Pathog,
5,
e1000330.
|
 |
|
|
|
|
 |
H.Kumar,
T.Kawai,
and
S.Akira
(2009).
Pathogen recognition in the innate immune response.
|
| |
Biochem J,
420,
1.
|
 |
|
|
|
|
 |
J.P.Parisien,
D.Bamming,
A.Komuro,
A.Ramachandran,
J.J.Rodriguez,
G.Barber,
R.D.Wojahn,
and
C.M.Horvath
(2009).
A shared interface mediates paramyxovirus interference with antiviral RNA helicases MDA5 and LGP2.
|
| |
J Virol,
83,
7252-7260.
|
 |
|
|
|
|
 |
J.Zou,
M.Chang,
P.Nie,
and
C.J.Secombes
(2009).
Origin and evolution of the RIG-I like RNA helicase gene family.
|
| |
BMC Evol Biol,
9,
85.
|
 |
|
|
|
|
 |
K.Haye,
S.Burmakina,
T.Moran,
A.García-Sastre,
and
A.Fernandez-Sesma
(2009).
The NS1 protein of a human influenza virus inhibits type I interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells.
|
| |
J Virol,
83,
6849-6862.
|
 |
|
|
|
|
 |
K.S.Childs,
J.Andrejeva,
R.E.Randall,
and
S.Goodbourn
(2009).
Mechanism of mda-5 Inhibition by paramyxovirus V proteins.
|
| |
J Virol,
83,
1465-1473.
|
 |
|
|
|
|
 |
K.Takahasi,
H.Kumeta,
N.Tsuduki,
R.Narita,
T.Shigemoto,
R.Hirai,
M.Yoneyama,
M.Horiuchi,
K.Ogura,
T.Fujita,
and
F.Inagaki
(2009).
Solution structures of cytosolic RNA sensor MDA5 and LGP2 C-terminal domains: identification of the RNA recognition loop in RIG-I-like receptors.
|
| |
J Biol Chem,
284,
17465-17474.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Rieder,
and
K.K.Conzelmann
(2009).
Rhabdovirus evasion of the interferon system.
|
| |
J Interferon Cytokine Res,
29,
499-509.
|
 |
|
|
|
|
 |
M.Schlee,
A.Roth,
V.Hornung,
C.A.Hagmann,
V.Wimmenauer,
W.Barchet,
C.Coch,
M.Janke,
A.Mihailovic,
G.Wardle,
S.Juranek,
H.Kato,
T.Kawai,
H.Poeck,
K.A.Fitzgerald,
O.Takeuchi,
S.Akira,
T.Tuschl,
E.Latz,
J.Ludwig,
and
G.Hartmann
(2009).
Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus.
|
| |
Immunity,
31,
25-34.
|
 |
|
|
|
|
 |
M.Schlee,
E.Hartmann,
C.Coch,
V.Wimmenauer,
M.Janke,
W.Barchet,
and
G.Hartmann
(2009).
Approaching the RNA ligand for RIG-I?
|
| |
Immunol Rev,
227,
66-74.
|
 |
|
|
|
|
 |
M.Yoneyama,
and
T.Fujita
(2009).
RNA recognition and signal transduction by RIG-I-like receptors.
|
| |
Immunol Rev,
227,
54-65.
|
 |
|
|
|
|
 |
O.Takeuchi,
and
S.Akira
(2009).
Innate immunity to virus infection.
|
| |
Immunol Rev,
227,
75-86.
|
 |
|
|
|
|
 |
P.Nakhaei,
P.Genin,
A.Civas,
and
J.Hiscott
(2009).
RIG-I-like receptors: sensing and responding to RNA virus infection.
|
| |
Semin Immunol,
21,
215-222.
|
 |
|
|
|
|
 |
P.Nakhaei,
T.Mesplede,
M.Solis,
Q.Sun,
T.Zhao,
L.Yang,
T.H.Chuang,
C.F.Ware,
R.Lin,
and
J.Hiscott
(2009).
The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation.
|
| |
PLoS Pathog,
5,
e1000650.
|
 |
|
|
|
|
 |
P.Ranjan,
J.B.Bowzard,
J.W.Schwerzmann,
V.Jeisy-Scott,
T.Fujita,
and
S.Sambhara
(2009).
Cytoplasmic nucleic acid sensors in antiviral immunity.
|
| |
Trends Mol Med,
15,
359-368.
|
 |
|
|
|
|
 |
R.Rad,
W.Ballhorn,
P.Voland,
K.Eisenächer,
J.Mages,
L.Rad,
R.Ferstl,
R.Lang,
H.Wagner,
R.M.Schmid,
S.Bauer,
C.Prinz,
C.J.Kirschning,
and
A.Krug
(2009).
Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori.
|
| |
Gastroenterology,
136,
2247-2257.
|
 |
|
|
|
|
 |
S.Goodbourn,
and
R.E.Randall
(2009).
The regulation of type I interferon production by paramyxoviruses.
|
| |
J Interferon Cytokine Res,
29,
539-547.
|
 |
|
|
|
|
 |
S.M.Horner,
and
M.Gale
(2009).
Intracellular innate immune cascades and interferon defenses that control hepatitis C virus.
|
| |
J Interferon Cytokine Res,
29,
489-498.
|
 |
|
|
|
|
 |
S.Myong,
S.Cui,
P.V.Cornish,
A.Kirchhofer,
M.U.Gack,
J.U.Jung,
K.P.Hopfner,
and
T.Ha
(2009).
Cytosolic viral sensor RIG-I is a 5'-triphosphate-dependent translocase on double-stranded RNA.
|
| |
Science,
323,
1070-1074.
|
 |
|
|
|
|
 |
T.Fujita
(2009).
A nonself RNA pattern: tri-p to panhandle.
|
| |
Immunity,
31,
4-5.
|
 |
|
|
|
|
 |
T.H.Mogensen
(2009).
Pathogen recognition and inflammatory signaling in innate immune defenses.
|
| |
Clin Microbiol Rev,
22,
240.
|
 |
|
|
|
|
 |
T.Kawai,
and
S.Akira
(2009).
The roles of TLRs, RLRs and NLRs in pathogen recognition.
|
| |
Int Immunol,
21,
317-337.
|
 |
|
|
|
|
 |
T.Shigemoto,
M.Kageyama,
R.Hirai,
J.Zheng,
M.Yoneyama,
and
T.Fujita
(2009).
Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes.
|
| |
J Biol Chem,
284,
13348-13354.
|
 |
|
|
|
|
 |
T.Wolff,
and
S.Ludwig
(2009).
Influenza viruses control the vertebrate type I interferon system: factors, mechanisms, and consequences.
|
| |
J Interferon Cytokine Res,
29,
549-557.
|
 |
|
|
|
|
 |
T.Xiao
(2009).
Innate immune recognition of nucleic acids.
|
| |
Immunol Res,
43,
98.
|
 |
|
|
|
|
 |
W.Zeng,
M.Xu,
S.Liu,
L.Sun,
and
Z.J.Chen
(2009).
Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3.
|
| |
Mol Cell,
36,
315-325.
|
 |
|
|
|
|
 |
X.Li,
C.T.Ranjith-Kumar,
M.T.Brooks,
S.Dharmaiah,
A.B.Herr,
C.Kao,
and
P.Li
(2009).
The RIG-I-like Receptor LGP2 Recognizes the Termini of Double-stranded RNA.
|
| |
J Biol Chem,
284,
13881-13891.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.Nie,
C.Viola,
C.Bieniossek,
S.Trowitzsch,
L.S.Vijay-Achandran,
M.Chaillet,
F.Garzoni,
and
I.Berger
(2009).
Getting a grip on complexes.
|
| |
Curr Genomics,
10,
558-572.
|
 |
|
|
|
|
 |
A.G.Bowie,
and
L.Unterholzner
(2008).
Viral evasion and subversion of pattern-recognition receptor signalling.
|
| |
Nat Rev Immunol,
8,
911-922.
|
 |
|
|
|
|
 |
A.Komuro,
D.Bamming,
and
C.M.Horvath
(2008).
Negative regulation of cytoplasmic RNA-mediated antiviral signaling.
|
| |
Cytokine,
43,
350-358.
|
 |
|
|
|
|
 |
A.Murali,
X.Li,
C.T.Ranjith-Kumar,
K.Bhardwaj,
A.Holzenburg,
P.Li,
and
C.C.Kao
(2008).
Structure and function of LGP2, a DEX(D/H) helicase that regulates the innate immunity response.
|
| |
J Biol Chem,
283,
15825-15833.
|
 |
|
|
|
|
 |
C.K.Pfaller,
and
K.K.Conzelmann
(2008).
Measles virus V protein is a decoy substrate for IkappaB kinase alpha and prevents Toll-like receptor 7/9-mediated interferon induction.
|
| |
J Virol,
82,
12365-12373.
|
 |
|
|
|
|
 |
K.Arimoto,
and
K.Shimotohno
(2008).
Regulation of viral recognition signaling by ubiquitin modification.
|
| |
Uirusu,
58,
47-54.
|
 |
|
|
|
|
 |
K.J.Ishii,
S.Koyama,
A.Nakagawa,
C.Coban,
and
S.Akira
(2008).
Host innate immune receptors and beyond: making sense of microbial infections.
|
| |
Cell Host Microbe,
3,
352-363.
|
 |
|
|
|
|
 |
L.Deng,
P.Dai,
T.Parikh,
H.Cao,
V.Bhoj,
Q.Sun,
Z.Chen,
T.Merghoub,
A.Houghton,
and
S.Shuman
(2008).
Vaccinia virus subverts a mitochondrial antiviral signaling protein-dependent innate immune response in keratinocytes through its double-stranded RNA binding protein, E3.
|
| |
J Virol,
82,
10735-10746.
|
 |
|
|
|
|
 |
M.Boyce,
C.C.Celma,
and
P.Roy
(2008).
Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts.
|
| |
J Virol,
82,
8339-8348.
|
 |
|
|
|
|
 |
M.U.Gack,
A.Kirchhofer,
Y.C.Shin,
K.S.Inn,
C.Liang,
S.Cui,
S.Myong,
T.Ha,
K.P.Hopfner,
and
J.U.Jung
(2008).
Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction.
|
| |
Proc Natl Acad Sci U S A,
105,
16743-16748.
|
 |
|
|
|
|
 |
M.Yoneyama,
and
T.Fujita
(2008).
Structural mechanism of RNA recognition by the RIG-I-like receptors.
|
| |
Immunity,
29,
178-181.
|
 |
|
|
|
|
 |
S.Hausmann,
J.B.Marq,
C.Tapparel,
D.Kolakofsky,
and
D.Garcin
(2008).
RIG-I and dsRNA-Induced IFNbeta activation.
|
| |
PLoS ONE,
3,
e3965.
|
 |
|
|
|
|
 |
T.Kubota,
M.Matsuoka,
T.H.Chang,
P.Tailor,
T.Sasaki,
M.Tashiro,
A.Kato,
and
K.Ozato
(2008).
Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression.
|
| |
J Biol Chem,
283,
25660-25670.
|
 |
|
|
|
|
 |
T.Saito,
D.M.Owen,
F.Jiang,
J.Marcotrigiano,
and
M.Gale
(2008).
Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA.
|
| |
Nature,
454,
523-527.
|
 |
|
|
|
|
 |
T.Saito,
and
M.Gale
(2008).
Differential recognition of double-stranded RNA by RIG-I-like receptors in antiviral immunity.
|
| |
J Exp Med,
205,
1523-1527.
|
 |
|
|
|
|
 |
T.Saito,
and
M.Gale
(2008).
[RIG-I mediated hepatic innate immune signaling that controls HCV infection]
|
| |
Uirusu,
58,
105-115.
|
 |
|
|
|
|
 |
T.Wolff,
F.Zielecki,
M.Abt,
D.Voss,
I.Semmler,
and
M.Matthaei
(2008).
Sabotage of antiviral signaling and effectors by influenza viruses.
|
| |
Biol Chem,
389,
1299-1305.
|
 |
|
|
|
|
 |
W.Barchet,
V.Wimmenauer,
M.Schlee,
and
G.Hartmann
(2008).
Accessing the therapeutic potential of immunostimulatory nucleic acids.
|
| |
Curr Opin Immunol,
20,
389-395.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |